Ketamine for the treatment of depression: What about the addictive potential? [4]

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 9, 2007, Pages 772-773

  Hillemacher, Thomas ^a   Bleich, Stefan ^a   Demling, Joachim ^a   Kornhuber, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; KETAMINE; NICOTINE;

ALCOHOL ABUSE; COMORBIDITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FOLLOW UP; HUMAN; LETTER; LOW DRUG DOSE; MAJOR DEPRESSION; PSYCHOSIS; RACEMIC MIXTURE; REPRODUCIBILITY; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ANESTHETICS, DISSOCIATIVE; DEPRESSIVE DISORDER, MAJOR; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TACHYPHYLAXIS; TREATMENT OUTCOME;

EID: 34547858910     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701517975     Document Type: Letter

References (5)

1. Zarate Jr, CA, Singh, JB and Carlson, PJ (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 63, pp. 856-864.
2. Pal, HR, Berry, N., Kumar, R. and Ray, R. (2002) Ketamine dependence. Anaesth Intensive Care, 30, pp. 382-384.
3. Wolffgramm, J., Galli, G., Thimm, F. and Heyne, A. (2000) Animal models of addiction: Models for therapeutic strategies?. J Neural Transm, 107, pp. 649-668.
4. Jansen, KL and Darracot-Cankovic, R. (2001) The nonmedical use of ketamine, part two: A review of problem use and dependence. J Psychoactive Drugs, 33, pp. 151-158.
5. Lahti, AC, Weiler, MA, Michaelidis, BA Tamara, Parwani, A. and Tamminga, CA. (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology, 25, pp. 455-467.